Monovalent Avian Influenza VLP (H5N1)

BIOLOGICAL2 trials

Sponsors

Novavax

Conditions

Influenza (Pandemic)

Phase 1

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1

CompletedNCT01594320

NovavaxInfluenza (Pandemic)

Start: 2012-04-30End: 2013-08-31Updated: 2014-02-06

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2

CompletedNCT01596725

NovavaxInfluenza (Pandemic)

Start: 2012-05-31End: 2013-08-31Updated: 2014-02-06